ArticleActa pharmaceutica Sinica. B2025
Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interaction.
Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.